Not available
Quote | Ardelyx Inc. (NASDAQ:ARDX)
Last: | $5.28 |
---|---|
Change Percent: | 17.44% |
Open: | $6.25 |
Close: | $5.28 |
High: | $6.4699 |
Low: | $5.07 |
Volume: | 22,525,977 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Ardelyx Inc. (NASDAQ:ARDX)
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx ( NASDAQ: ARDX ) stated Thursday it has signed a financing deal with HealthCare Royalty Partners to receive up to $20M on the the sale of its future royalties and sales milestones from Kyowa Kirin. Kyowa Kirin is Ardelyx' collaboration partner in Japan fo...
Message Board Posts | Ardelyx Inc. (NASDAQ:ARDX)
Subject | By | Source | When |
---|---|---|---|
$ARDX Are we heading down to the daily | TripTrap | investorshub | 04/28/2023 2:08:33 PM |
1 year chart. You don't even need | Cosa | investorshub | 04/27/2023 9:07:48 PM |
Benny $ARDX is a BP buyout candidate like | Whalatane | investorshub | 04/22/2023 10:16:59 PM |
Agree. It looks fabulous! Would | Cosa | investorshub | 04/19/2023 8:28:20 PM |
If an offering occurs after approval and is, | Benny450 | investorshub | 04/19/2023 4:55:57 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
17.44%Change Percent:
Ardelyx Inc. Company Name:
ARDX Stock Symbol:
NASDAQ Market:
Ardelyx Inc. Website:
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...